calocurb glp 1 Calocurb® CLINICAL Calocurb GLP-1 Activator – Clinically
Description
This is partly due to lixisenatides better ability to slow gastric emptying, yielding a better glucose control and, thus, reduced administration frequency [53]
Accessed May 1 2018
Moreover, it delays gastric emptying and suppresses appetite
Rosenstock J, Ferrannini E
Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, et al
